Hutchmed (China)
HCM
Enerpac Tool
EPAC
Ermenegildo Zegna NV
ZGN
Lantheus
LNTH
eBay
EBAY
US Stock MarketDetailed Quotes
VCYT Veracyte
- 33.460
- -5.900-14.99%
Close Feb 25 16:00 ET
- 33.520
- +0.060+0.18%
Pre 04:43 ET
2.59BMarket Cap107.94P/E (TTM)
38.785High32.670Low2.60MVolume36.100Open39.360Pre Close88.62MTurnover3.37%Turnover Ratio107.94P/E (Static)77.50MShares47.31652wk High2.21P/B2.58BFloat Cap18.61052wk Low--Dividend TTM77.18MShs Float86.030Historical High--Div YieldTTM15.54%Amplitude4.210Historical Low34.065Avg Price1Lot Size
About Veracyte Company
Veracyte, Inc. engages in the research, development and commercialization of diagnostic products. The firm's portfolio includes Afirma, Percepta, and Envisia. It intends to treat thyroid cancer, improve lung cancer screening, and clarify the diagnosis of idiopathic pulmonary fibrosis. The company was founded by Bonnie H. Anderson and Y. Douglas Dolginow on August 15, 2006 and is headquartered in South San Francisco, CA.
Company Profile
SymbolVCYT
Company NameVeracyte
Listing DateOct 30, 2013
Issue Price13.00
Founded2006
CEOMr. Marc A. Stapley
MarketNASDAQ
Employees815
Fiscal Year Ends12-31
Address6000 Shoreline Court,Suite 300
CitySouth San Francisco
ProvinceCalifornia
CountryUnited States of America
Zip Code94080
Phone1-650-243-6300
Websitehttp://www.veracyte.com
Company Executives
- Name
- Position
- Salary
- Marc A. Stapley
- Chief Executive Officer and Director
- 7.18M
- Rebecca Chambers
- Chief Financial Officer
- 2.78M
- Dr. Phillip G. Febbo, M.D.
- Chief Scientific and Chief Medical Officer
- 3.79M
- Jonathan Wygant
- Chief Accounting Officer
- --
- Dr. John Leite
- Chief Commercial Officer, CLIA
- 1.92M
- Annie McGuire
- General Counsel and Chief People Officer
- 2.48M
- Dr. Robert S. Epstein, M.D.,M.S.
- Chairman of the Board
- 337.98K
- Dr. Tom Miller, PhD
- Director
- --
- Brent Shafer
- Director
- --
- Muna Bhanji, Ph.
- Independent Director
- 299.98K
- Dr. Eliav Barr, M.D.
- Independent Director
- 294.98K
- Evan Jones
- Independent Director
- 314.98K
- Karin Eastham
- Independent Director
- 314.98K
- Jens Holstein
- Independent Director
- 327.47K